Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
N-Molecular is a clinical laboratory and biotechnology company that specializes in high-complexity molecular diagnostics and precision medicine. Headquartered in Rockville, Maryland, the company operates a CLIA-certified and CAP-accredited facility providing advanced testing services such as pharmacogenomics, cancer genomics, and infectious disease diagnostics. Their proprietary platform leverages Next-Generation Sequencing (NGS) and quantitative PCR to provide clinicians with detailed genetic data for personalized treatment planning. N-Molecular's mission is to bridge the gap between genomic science and clinical practice, focusing on therapeutic areas like oncology, cardiology, and mental health. The company also maintains a research and development arm focused on proprietary molecular targeting technologies for both diagnostic and therapeutic applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on N-Molecular.